Institute for Transformative Molecular Medicine
ÐÓ°ÉÊÓƵ
Dahms Clinical Research Unit (DCRU)
University Hospitals Main Campus
11100 Euclid Avenue, Cleveland, Ohio
Eligible Participants: Adults 18-35 years old, no preexisting diseases
Participants will be asked to donate 1 unit of blood, then receive either of their blood back or normal saline 3 weeks later while breathing an experimental drug designed to improve outcomes of blood transfusion.
There will be 4 study visits:
- Initial health screen at the University Hospitals Main Campus
- Blood donation at the American Red Cross (3747 Euclid Ave, Cleveland
- Second health screen at the UH Main Campus
- Blood transfusion, drug administration, and an overnight stay at DCRU
The study includes having your blood drawn, having an IV inserted in a vein in your arm, and having a tube placed in. an artery in your wrist (an arterial line or arterial catheter).
Financial compensation is provided.
For more information, contact:
Dr Batuhan Degis 216-334-9277
The University Hospitals Research
Coordinator Core
1-833-78TRIAL (1-833-788-7425)
reference STUDY 20221492 Or visit:
